Zantac, the popular heartburn drug, has been the subject of a nationwide recall. The medication and other ranitidine-based drugs have tested positive for N-Nitrosodimethylamine (NDMA), a chemical that is known as a probable carcinogen.
Primarily, the types of cancer associated with the use of Zantac are cancers of the digestive and urinary systems. Zantac may cause the development of bladder cancer.
Bladder cancer can be caused by tobacco use, chemical exposure, radiation exposure, irritation, and infection.
The most common bladder cancer symptom is blood in the urine. Any severe pain while urinating, or changes in the appearance or frequency of urination, could be a sign of bladder cancer.
The following symptoms may be signs of bladder cancer. If you are experiencing any of these symptoms, contact a doctor immediately:
- Blood in the urine
- Dark urine
- Frequent urination
- Painful urination
- Pain in the back/kidneys or pelvis
The presence of NDMA in Zantac has been reported as a potential result of reactions with ranitidine during digestion. Due to these reactions, small amounts of NDMA may increase within the body and contribute to the development of bladder cancer and other types of cancer.
If you are experiencing signs of bladder cancer, you should seek medical attention as soon as possible. Early detection and prompt treatment can increase your chances of a successful recovery.
You may require Zantac as part of your regular heartburn treatment plan. There are several other medications that do not contain ranitidine and serve the same purpose as Zantac. Your doctor can advise you on your future heartburn treatment in addition to addressing any symptoms of bladder cancer.
Once you have received the proper medical care, contact Spangenberg Shibley & Liber LLP. Our legal team can help you recover the compensation you deserve.To schedule a free consultation with our attorneys, complete our contact form or call (216) 600-0114.